Organism name | Boswellia papyrifera |
---|---|
Genus | Boswellia |
Family | Burseraceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Boswellia |
---|---|
Linked NCBI taxonomy ID | 80276 |
Linked level | genus |
Family in NCBI taxonomy | Burseraceae |
---|---|
ID | 4014 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00042045
![]() |
11-Keto-beta-boswellic acid
|
CHEMBL437964
CHEMBL236501 |
6 / 2 / 3 | No. 13 | No. 51 |
![]() |
||
C00036795
![]() |
beta-Boswellic acid
|
CHEMBL267225
CHEMBL391836 |
C054625
|
7 / 0 / 1 | 2 / 0 | No. 13 | No. 51 |
![]() |
C00042114
![]() |
3alpha-Acetoxy-27-hydroxylup-20(29)-en-24-oic acid
/ (+)-3alpha-Acetoxy-27-hydroxylup-20(29)-en-24-oic acid |
CHEMBL499293
|
1 / 0 / 0 | No. 23 | No. 51 |
![]() |
||
C00003672
![]() |
Sitosterol
/ beta-sitosterl / (-)-beta-Sitosterol / Stigmast-5-en-3beta-ol |
CHEMBL221542
CHEMBL1398443 CHEMBL1875388 |
17 / 19 / 12 | No. 53 | No. 11 |
![]() |
||
C00042279
![]() |
beta-Elemonic acid
|
CHEMBL498242
CHEMBL566929 |
3 / 0 / 0 | No. 86 | No. 51 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P48147 | Prolyl endopeptidase | S9A | C00036795 C00042045 C00042114 C00042279 | 0 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00003672 C00036795 C00042045 | 0 / 0 |
P80365 | Corticosteroid 11-beta-dehydrogenase isozyme 2 | Enzyme | C00003672 C00042045 | 1 / 1 |
P17706 | Tyrosine-protein phosphatase non-receptor type 2 | Tyr | C00036795 C00042045 | 0 / 1 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00036795 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00003672 | 0 / 0 |
Q8TDU6 | G-protein coupled bile acid receptor 1 | Steroid-like ligand receptor | C00042279 | 0 / 0 |
P08047 | Transcription factor Sp1 | Unclassified protein | C00003672 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00003672 | 3 / 2 |
P08183 | Multidrug resistance protein 1 | drug | C00003672 | 1 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00003672 | 0 / 1 |
O14684 | Prostaglandin E synthase | Enzyme | C00036795 | 0 / 0 |
P28845 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | Enzyme | C00042045 | 1 / 1 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00042045 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00003672 | 0 / 0 |
P00734 | Prothrombin | S1A | C00003672 | 4 / 2 |
P14679 | Tyrosinase | Oxidoreductase | C00003672 | 4 / 2 |
Q96RI1 | Bile acid receptor | NR1H4 | C00042279 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00003672 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00003672 | 1 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00003672 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00003672 | 0 / 1 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00036795 | 0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00003672 | 2 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00036795 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00003672 | 1 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00003672 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
7150 | TOP1, TOPI | topoisomerase (DNA) I (EC:5.99.1.2) |
C00036795
|
7153 | TOP2A, TOP2, TP2A | topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) |
C00036795
|
OMIM | preferred title | UniProt |
---|---|---|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#218030 | Apparent mineralocorticoid excess; ame |
P80365
|
#604931 | Cortisone reductase deficiency 1; cortrd1 |
P28845
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#615363 | Estrogen resistance; estrr |
P03372
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
#613679 | Prothrombin deficiency, congenital |
P00734
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#601367 | Stroke, ischemic |
P00734
|
#188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
KEGG | name | UniProt |
---|---|---|
H00223 | Inherited thrombophilia |
P00734
(related)
|
H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00038 | Malignant melanoma |
P14679
(marker)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00408 | Type I diabetes mellitus |
P17706
(related)
|
H01111 | Cortisone reductase deficiency (CRD) |
P28845
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00259 | Apparent mineralocorticoid excess syndrome |
P80365
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|